I'm sorry to hear that Fuzzy.

Here is what I have from my RVX DD file:

OVARIAN CANCER (Chemotherapy resistant)

https://cdrjournal.com/article/view/3918

Results: High ABCA1 mRNA and protein expression was found to be significantly associated with poor patient outcome. ABCA1 mRNA and protein levels were significantly increased in ovarian cancer cell lines (OVCAR-5 CBPR and CaOV3 CBPR) with acquired carboplatin resistance. ABCA1 mRNA was significantly increased in primary HGSOC cells obtained from patients with acquired chemotherapy resistance. Apabetalone treatment reduced ABCA1 protein expression and increased the sensitivity of both parental and carboplatin-resistant ovarian cancer cells to carboplatin.

https://www.nature.com/articles/s41416-021-01321-0